[Heart surgery and interventional cardiology for adults; Health Council recommendations]

K I Lie1

  • 1Academisch Ziekenhuis, Thoraxcentrum, Groningen.

Insights

The Dutch Health Council recommends combined heart team discussions and central data registration for coronary heart disease interventions like coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA). Quality standards include minimum intervention volumes for heart surgeons and cardiologists, aiming for shorter waiting lists.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Public Health Policy

Background:

  • The Dutch Health Council's report addresses advancements in invasive treatments for coronary artery diseases.
  • Key procedures discussed include coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA).

Purpose of the Study:

  • To provide advice on the future developments of invasive cardiology and heart surgery for adults.
  • To establish quality standards and recommendations for treatment centers and waiting times.

Main Methods:

  • The report is based on a scientifically solid foundation.
  • It involves expert advice and consideration of current practices in cardiac interventions.

Main Results:

  • Advocates for multidisciplinary heart team discussions for CABG and PTCA indications.
  • Proposes central data registration and minimum annual intervention volumes (150 for heart surgeons, 100 for intervention cardiologists) for quality assurance.
  • Recommends a maximum waiting time of 2-3 months for procedures.

Conclusions:

  • Centralized approaches and quality standards are recommended despite government deregulation trends.
  • The report aims to optimize patient outcomes and healthcare efficiency in adult cardiac interventions.

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...